Expertise
EU market entry for MedTech and diagnostics companies
We help MedTech and diagnostics companies from the United States, Canada and Asia plan their entry into the European Union, from the regulatory route to the first distributor. We are based in France and prepare the documents each step requires.
Who it is for
- US and Canadian MedTech companies with a cleared or approved product that now look to Europe
- Asian diagnostics and device manufacturers seeking European distributors and partners
- Companies that need a realistic market-entry plan to present to their board or investors
- Teams that need a European base for meetings, coordination and follow-through
What we deliver
- Regulatory pathway assumptions, submission roadmap and evidence gap assessment for the EU
- Source-based market and competitor landscape, customer segments and opportunity assessment
- Market-entry plan, channel strategy, launch roadmap and performance indicators
- Distributor scorecards, diligence questions, onboarding plans and training materials
- Partner criteria, target list, company summaries, outreach drafts and meeting briefs
- Product brochures, sales presentations and hospital-facing materials adapted for European audiences
How it works
- Discovery: your product, its current approvals, the target countries and the decisions you need to make.
- Proposal: deliverables, inputs, responsibilities, fees, schedule and review cycles, agreed in writing.
- Delivery: we assess the market and the evidence and prepare the agreed plans and materials.
- Review: your team, your regulatory lead and qualified specialists validate the content before it is used.
Why WyteRock
- European base, global outlook: we are based in France, work across borders and know the European regulations.
- Evidence before assertion: market figures and claims are traced to their sources, and assumptions are labelled as such.
- Specialists where regulation requires: regulated steps are coordinated with qualified professionals, not improvised.
Regulatory submissions, the roles of EU authorised representative and person responsible for regulatory compliance, certification and legal agreements remain with qualified specialists, notified bodies and lawyers; WyteRock prepares the supporting documents and coordinates the work.
Questions
Can you help an FDA-cleared device launch in Europe?
Yes. We map the EU MDR route that matches your FDA clearance, the evidence still needed and the market-access plan for the first European countries.
Does FDA clearance or Health Canada approval give access to the EU market?
No. Devices and diagnostics placed on the EU market must meet the EU MDR or IVDR. Existing evidence may be reused where it fits, which a gap assessment establishes.
Can you act as our EU authorised representative?
No. We can prepare the documents that role requires and coordinate with qualified providers who hold it.
Which countries do you cover?
Our plans address the EU as a whole and the specific countries you prioritise. The scope is agreed in the written proposal.
How long does a market-entry plan take?
It depends on the product, the number of countries and the evidence available. The schedule is set in the proposal.